BillionToOne

BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.

Website

billiontoone.com

City

San Francisco

Country

United States

YC batch

Summer 2017

Team

300 people

Stage

Public

AI-native

No

Hiring

Open roles

See it on the San Francisco mapSource Spot something wrong?

Claim this profile

Free and instant: prove you run billiontoone.com and edit the profile yourself.

• Your logo, office address and founder photos
• The ✓ Verified mark next to BillionToOne across the site
• Open roles listed on the Hiring board
• A followed link back to your website

A rank card with BillionToOne's standing on Labspie, or a simple badge. Both link to this profile and update themselves.

Rank cardBadge

DarkLight

<a href="https://labspie.com/c/billiontoone" title="BillionToOne is listed on Labspie"><img src="https://labspie.com/card/billiontoone-dark.svg" alt="BillionToOne is listed on Labspie" width="400" height="88"></a>

Copy embed code